Marijuana rescheduling status: cannabis remains a Schedule I controlled substance under federal law. The Drug Enforcement Administration proposed moving marijuana to Schedule III in May 2024, and that proposal has not become a final rule. The administrative process stalled through hearing delays and procedural orders, so rescheduling is pending rather than complete.
dea schedule 3 cannabis implications
What rescheduling means
Rescheduling changes how a substance is placed under the Controlled Substances Act. It is an agency action, not a new statute from Congress. The CSA groups controlled substances into five schedules based on accepted medical use and potential for abuse. Schedule I is the most restrictive tier, reserved for drugs with no accepted medical use and a high potential for abuse. Schedule III covers substances with moderate to low physical dependence potential, such as ketamine and anabolic steroids.
dea schedule 3 cannabis implications
Moving marijuana to Schedule III would not turn it into a legal consumer product. It would change how federal law treats it for tax, research, and regulatory purposes.
what does rescheduling do for cannabis
Timeline of the current effort
- October 2022: the White House asked the Department of Health and Human Services (HHS) and the Department of Justice to review how cannabis is scheduled.
- August 2023: HHS finished its scientific review and recommended Schedule III.
- May 2024: DEA published a proposed rule in the Federal Register to move marijuana to Schedule III.
- 2024: the public comment period drew a large volume of responses and was extended.
- Late 2024 into 2025: a requested administrative hearing was scheduled, postponed, and later set aside while the presiding judge directed the parties to file written arguments.
- Now: no final rule and no effective date. Schedule I is still the operative classification.
Why the timeline keeps moving
Rescheduling runs through formal rulemaking, which includes a comment period and the option of an administrative hearing where supporters and opponents can contest the evidence. That hearing track produced scheduling disputes and repeated delays. Leadership changes at DOJ and DEA also shift priorities, and any final rule can face court review afterward. Each step adds months.
What would change under Schedule III
- Federal taxes: Section 280E blocks deductions for businesses that traffic in Schedule I or II substances. Schedule III would remove that obstacle for state-legal operators.
- Banking and investment: a lower schedule could ease some compliance friction, though it would not amount to federal legalization.
- Research: registration and access for studies would become simpler.
- Criminal exposure: possession without a prescription would still violate federal law, since Schedule III drugs are legal only with a prescription.
- State markets: medical and adult-use programs would still be governed by state law.
What rescheduling would not do
It would not legalize recreational marijuana, create a federal right to buy cannabis, or override state licensing rules. A state-licensed dispensary would not become a federally compliant pharmacy. Rescheduling is also separate from the 2018 action that placed a prescription CBD medicine in Schedule V.
Is marijuana still federally illegal?
Yes. Cannabis stays in Schedule I until a final rule takes effect or Congress changes the law. State legalization does not alter the federal classification.
Does any of this change a dispensary visit?
No. In a state with a legal program, purchases continue under state rules, and the pending federal proposal does not change that. If Schedule III were finalized, the practical effects would show up first in taxes, banking, and research rather than at the register.
Could cannabis land in a different schedule?
Possible. DEA is not required to follow the HHS recommendation. Commenters argued for full removal from the schedules and for keeping Schedule I, so the final outcome could differ from the proposal.
What to watch
- A final rule from DEA, or a decision to withdraw the proposal.
- Whether the administrative hearing resumes.
- Congressional bills that would deschedule or legalize cannabis.
- Executive action from the White House.
Because this process moves in steps, treat any single date as provisional and check the Federal Register and DEA announcements for the current position.